Cart
sales@molnova.com
GNE-7883
CAS No. 2648450-42-2
GNE-7883( —— )
Catalog No. M37199 CAS No. 2648450-42-2
GNE-7883 is an inhibitor targeting TEAD transcription factor, inhibits cell proliferation and suppresses YAP/TAZ activation, and can be used to study YAP/TAZ-dependent tumors.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 311 | In Stock |
|
| 5MG | 282 | In Stock |
|
| 10MG | 455 | In Stock |
|
| 25MG | 747 | In Stock |
|
| 50MG | 1004 | In Stock |
|
| 100MG | 1414 | In Stock |
|
| 200MG | 1841 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGNE-7883
-
NoteResearch use only, not for human use.
-
Brief DescriptionGNE-7883 is an inhibitor targeting TEAD transcription factor, inhibits cell proliferation and suppresses YAP/TAZ activation, and can be used to study YAP/TAZ-dependent tumors.
-
DescriptionGNE-7883 is a pan-TEAD inhibitor with anti-cell proliferation activity. GNE-7883 overcomes resistance to KRAS G12C inhibitors in multiple preclinical models by inhibiting YAP/TAZ activation. GNE-7883 may be used in the study of YAP/TAZ-dependent cancers.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorYAP
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2648450-42-2
-
Formula Weight500.57
-
Molecular FormulaC28H29FN6O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (199.77 mM; Ultrasonic )
-
SMILESO=C1C=C(NC2=C(C(=O)N3CC(CF)C3)C(=NN12)C=4N=CC=NC4C)C=5C=CC(=CC5)C6CCCCC6
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Hagenbeek TJ, et al. An allosteric pan-TEAD inhibitor blocks oncogenic YAP/TAZ signaling and overcomes KRAS G12C inhibitor resistance. Nat Cancer. 2023 Jun;4(6):812-828.?
molnova catalog
related products
-
Acesulfame Potassium
Acesulfame potassium is a non-nutritive sweetener.
-
(3b,4a,11a,16b)-16,2...
(3b,4a,11a,16b)-16,23,28-Trihydroxy-11-methoxyolean-12-en-3-yl O-6-deoxy-a-L-mannopyranosyl-(1 4)-O-[b-D-glucopyranosyl-(1 6)]-b-D-glucopyranoside
-
PSMA-11
PSMA-11 (HBED-CC-PSMA) detects prostate cancer recurrence and metastasis by binding to the extracellular structural domain of prostate-specific membrane antigen (PSMA).
